Evaluation of the Biocompatibility of a Recent Bioceramic Root Canal Sealer (BioRoot™ RCS): In-vivo Study by El-Mansy, Laila Hussein et al.
100 https://www.id-press.eu/mjms/index
Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia
Open Access Macedonian Journal of Medical Sciences. 2020 Apr 15; 8(D):100-106.
https://doi.org/10.3889/oamjms.2020.4361
eISSN: 1857-9655
Category: D - Dental Sciences
Section: Dental Pathology and Endodontics
Evaluation of the Biocompatibility of a Recent Bioceramic Root 
Canal Sealer (BioRoot™ RCS): In-vivo Study
Laila Hussein El-Mansy1*, Magdy Mohamed Ali1, Reham EL Sayed Hassan2, Khaled Ali Beshr1, Salma Hassan El Ashry3
1Department of Endodontic, Faculty of Dentistry, Beni-Suef University, Egypt; 2Department of Endodontic, Faculty of Dentistry, 
Minia University, Egypt; 3Department of Endodontic, Faculty of Dentistry, Ain Shams University, Egypt
Abstract
BACKGROUND: Recently, new calcium silicate bioceramic sealers were introduced to the market. The selection of 
root canal sealers should not only be based on the different physical parameters but also on local biocompatibility 
and tissue tolerance.
AIM: This study aimed to evaluate and compare the in-vivo biocompatibility of a BioRoot RCS in parallel to MTA 
Fillapex and AH Plus sealers.
METHODS: Polyethylene tubes containing the freshly mixed test materials were implanted in the subcutaneous 
tissue of 32 Wistar rats. Empty tubes served as negative controls. After 7, 14, 30, and 60 days, the animals were 
sacrificed, and the implants with surrounding tissues were processed for routine histological analysis. Histological 
sections were analyzed under light microscopy. The tissue response was determined by the inflammatory cell 
infiltration intensity and the fibrous capsule thickness.
RESULTS: Results revealed a statistically significant decrease of the inflammation intensity by time within each 
group for all tested sealers and control. A well-defined thin capsule was observed for all tested sealers at 60 days.
CONCLUSION: BioRoot RCS exhibited rapid recovery of inflammation similar to controls. Thus, within the limitations 
of this study, it can be considered a biocompatible sealer with acceptable tissue tolerance.
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Introduction
The endodontics face is constantly changing 
due to the technical and material advancements. 
Bioceramics are the most distinguished recently 
introduced materials in endodontics, due to their superior 
physical properties, biocompatibility and bioactivity by 
deposition of hydroxyapatite which greatly increase the 
seal at the dentin-sealer interface [1], [2], [3].
Recently, new tri-calcium silicate bioceramic 
sealers were introduced to the market for dental use. 
Selection of root canal sealers should not be based only 
on the different physical parameters, but also on local 
biocompatibility and tissue tolerance [4], [5]. Calcium 
silicate-based materials are acknowledged as bioactive 
materials because they are proved to simulate the 
deposition of mineralized tissues and repair [3], [6], [7].
Biocompatibility is one of the most essential 
prerequisites of root canal filling materials. Endodontic 
sealers can get in direct contact with periapical tissues and 
may trigger adverse reactions affecting periapical repair 
and the final outcome of endodontic treatment [8], [9]. All 
sealers available in practices exhibit a degree of toxicity, 
thus extrusion of sealers into periapical area should be 
avoided [10]. Root canal sealers should have acceptable 
tissue tolerance to preclude or heal apical periodontitis. 
Up-to-date, no sealer fulfilled all Grossman’s [11] criteria 
of an ideal endodontic sealer [9].
BioRoot™ RCS (Septodont, France) is a 
recently introduced tri-calcium silicate-based bioceramic 
sealer. It utilizes the “Active Biosilicate Technology” 
which is resin and eugenol free, providing exceptional 
biological and bioactive properties [12].
Several studies investigated the physical 
properties of BioRoot [13], corroborating its 
bioactive properties and its relatively lower 
cytotoxic [14], [15], [16], [17], [18] and genotoxic [19] 
profile compared to other sealers.
MTA Fillapex (Angelus, Brazil) is a salicylate 
resin bioceramic sealer, with enhanced physical 
properties but has been shown to be relatively cytotoxic 
and genotoxic [15], [19], [20].
AH Plus (Dentsply, Germany) a resin 
epoxy-based sealer is considered the gold standard 
 El-Mansy et al. In Vivo Biocomaptibilty of a Bioceramic Sealer
Open Access Maced J Med Sci. 2020 Apr 15; 8(D):100-106. 101
of endodontic sealers because of its excellent 
physicochemical properties [21], [22].
Biocompatibility evaluation of newly introduced 
materials involves initial in-vitro assessment of the 
cytotoxicity, followed by preliminary in-vivo studies in 
laboratory animals and clinical studies [23], [24], [25].
Subcutaneous implantation is an in-vivo 
method simulating the clinical conditions, used to 
evaluate the tissue response of newly introduced dental 
materials [7], [26].
In previous in-vitro cytotoxicity assays, BioRoot 
RCS sealer showed superior biocompatibility [17], [19] on 
pulpal stem cells [16] and periodontal ligament cells [18].
Nevertheless, although BioRoot-RCS seems 
to be a promising material, to the best of our knowledge, 
this is the first in-vivo study to evaluate its biological 
safety. Thus, our study was conducted to evaluate 
the in-vivo biocompatibility of the recently introduced 
calcium silicate bio-ceramic sealer (BioRoot RCS) 
compared to MTA Fillapex and AH Plus.
Materials and Methods
The present study was approved by the Ethical 
Committee of the Faculty of Dentistry, Minia University. 
(No: 260/2018). All experimental procedures conformed 
to the international guiding principles for biomedical 
research involving animals and relevant guidelines [27].
Selection of the animal model
Thirty-two male Wistar rats, with an average 
weight of (280–300 g) and average age of (4–5) months, 
were selected. The sample size was established based 
on previous research [7], [28], [29]. Animals were 
housed in a climatized room, with a 12 h day-night cycle 
at a temperature of 24 ± 2°C. All animals were fed with 
a semi-purified diet and water ad libitum. Animals were 
then given water only 12 h before surgery. The animals 
were divided into four equal groups (8 rats each) 
according to the observation periods (7 days, 14 days, 
30 days, and 60 days) post-implantation.
Surgical implantation procedures
The surgical procedures were performed 
following previous studies [7], [29], [30]. The tested 
materials were freshly prepared according to the 
manufacturers’ instructions and placed in sterile 
polyethylene tubes.
Animals were anesthetized by intraperitoneal 
administration of 10% ketamine hydrochloride (80 mg/kg) 
associated with xylazine hydrochloride (10 mg/kg). After 
shaving and disinfection of surgical sites, four incisions 
(2 cm) were performed. Then, two scapular and two 
caudal pockets were created using a blunt scissor, to 
accommodate the polyethylene tubes.
Four sterile polyethylene tubes were implanted 
in the dorsal region of each rat (n = 4), one empty 
tube as a control and the others filled with the tested 
sealers [7], [30]. All surgical incisions were closed with 
#3–0 black silk sutures Figure 1.
Figure 1: (a-d) Surgical implantation of polyethylene tubes
After surgery, animals of each group were 
individually housed and maintained on semi-purified 
died and water. At each observation period, eight 
animals were sacrificed by anesthetic overdose and the 
tubes were excised with the surrounding tissues.
Specimens preparation and 
histopathological evaluation
The specimens were fixed in 10% formalin for 
48 h and coded according to the tested material and the 
observation time. The polyethylene tubes were carefully 
removed through a small incision [31].
Specimens were then embedded in paraffin 
blocks. Serial sections of 4 µm thickness were 
prepared by a rotary microtome for further staining with 
hematoxylin and eosin stain (H&E).
Histological sections were analyzed at different 
magnifications, under a light microscope (Olympus CX31, 
Ireland) by an experienced pathologist blinded to materials 
type and implantation intervals. The tissue response was 
determined by the inflammatory cell infiltration intensity and 
the fibrous capsule thickness. The inflammatory events 
were scored based on previous studies [9], [32], [33] as 
a
c d
b
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follows: (1) Few or absent; (2) mild; (3) moderate, and (4) 
severe reaction. Fibrous capsules were considered thin 
when <150 µm and thick when ≥150 µm.
Statistical analysis
Data management and statistical analysis 
were performed using the Statistical Package for 
the Social Sciences (SPSS) version 18. Data were 
explored for normality by checking the data distribution 
and using Kolmogorov–Smirnov and Shapiro–Wilk 
tests. Categorical data were summarized as count 
and percentages. Non-normally distributed numeric 
variables were compared between groups by Kruskal–
Wallis, and pairwise comparison was performed using 
Mann–Whitney U test. Comparisons over time regarding 
numeric variables were done by Friedman test. For 
categorical variables, differences were analyzed with 
Chi-square test. Adjustments of p value were done 
using the Bonferroni method for multiple testing. 
p ≤ 0.05 were considered statistically significant.
Results
Representative images of the subcutaneous 
tissue reactions (between host tissue and implanted 
tube opening) in the control and sealer groups are 
shown in Figure 2 (A-D) and the histological analysis is 
summarized in Tables 1 and 2 and Figures 3-5.
Figure  2:  Representative  images  of  the  subcutaneous  tissue  reactions.  Control  Group  1:  (1A) Moderate  inflammatory  response  (arrow), 
(1B) mild  inflammatory  reaction and  thick fibrotic  capsule  (arrow),  (1C and 1D) absence of  inflammation and  thin mature fibrous capsule 
(arrows). BioRoot RCS Group 2: (2A) Severe inflammatory cells infiltration with marked angiogenesis (arrows), (2B) mild inflammation with 
thick fibrotic capsule (arrow), (2C) well organized fibrous capsule with mild reaction (arrow), (2D) no  inflammation with thin mature fibrous 
capsule (arrow). AH Plus Group 3: (3A) Tissue necrosis on the tubular orifice and severe inflammatory cell infiltration (arrow). (3B) Thick fibrous 
capsule, moderate infiltration (arrow), (3C) mild inflammation with clear tube orifice without necrotic tissues (arrow), (3D) thin mature fibrous 
capsule with the absence of inflammation (arrow). MTA Fillapex Group 4: (4A) Extensive tissue necrosis and severe inflammatory reaction 
(arrow). (4B) Thin layer of necrotic tissue with black brownish-leaked deposits of the tested material (arrows). (4C) Mild reaction with clear tube 
orifice without necrotic tissues (arrow). (4D) Thin mature fibrous capsule with non-significant inflammation (arrow). A, B, C, and D conform to 
post-implantation observation periods 7, 14, 30, and 60 days, respectively (H&E ×400)
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The same letters indicate the absence of 
statistical differences among the groups in each analysis 
period.
Discussion
The evaluation of biocompatibility of any dental 
material intended for clinical use necessitate a planned 
assessment in sequential stages, including in-vitro cell 
line cultures, tissue reaction in animals, and clinical trials, 
to protect the patient from possible hazards [25], [34].
Table 1: Histological analysis scores for all groups
Time/n Materials Inflammation scores Median Capsule thickness
1 2 3 4 Thick Thin
7 days n=8 Control 0 2 5 1 3a 8 0
BioRoot RCS 0 1 2 5 4a 8 0
AH Plus 0 1 3 4 3.5a 7 1
MTA Fillapex 0 1 1 6 4a 7 1
p value=0.136 ns p=0.54 ns
14 days n=8 Control 0 5 3 0 2a 4 4
BioRoot RCS 0 4 3 1 2.5a 5 3
AH Plus 0 2 4 2 3a 8 0
MTA Fillapex 0 1 4 3 3a 7 1
p value=0.084 ns p=0.083 ns
30 days n=8 Control 7 1 0 0 1b 0 8
BioRoot RCS 2 6 0 0 2a 1 7
AH Plus 0 6 1 1 2a 3 5
MTA Fillapex 3 4 1 0 2a 6 2
p value=0.004 ns p=0.006 ns
60 days n=8 Control 8 0 0 0 1a 0 8
BioRoot RCS 7 1 0 0 1a 0 8
AH Plus 7 1 0 0 1a 0 8
MTA Fillapex 6 2 0 0 1a 1 7
p value=0.529 ns p=0.38 ns
Significance level p≤0.05, *significant, ns=non-significant.
At 7 days, histological analysis revealed that 
all tested sealers showed severe inflammatory cell 
infiltration in a thick poorly organized fibrous capsule,
Table 2: Effect of time on the inflammatory intensity and 
capsule thickness within the same group
Variable Inflammatory scores Capsule thickness
Control 0.00* p=0.0002*
BioRoot RCS 0.00* p=0.0002*
AH plus 0.00* p=0.0014*
MTA Fillapex 0.00* p=0.0002*
Significance level p≤0.05, *significant
while the controls showed moderate inflammation at the 
tube orifice. Marked angiogenesis (arrows) was observed 
in all test groups (Figure 2, A1–4). However, a significant 
difference was not observed among the groups (p > 0.05).
At 14 days, BioRoot RCS showed rapid recovery 
and mild inflammatory response similar to control. AH 
Plus and MTA Fillapex exhibited greater inflammation 
than controls, while three MTA Fillapex specimens 
exhibited a severe median score. The fibrous capsule 
was thick in all specimens of each group in this period 
(Figure 2, B1–4). There were no statistically significant 
differences between the study periods.
At 30 days, the inflammatory reaction 
significantly declined over time for all tested groups 
at (p = 0.04). Most of the specimens had mild 
inflammatory cell infiltration, while control specimens 
had no inflammation (median score: 1). A significant 
difference was observed between BioRoot RCS, MTA 
Fillapex, and AH Plus when compared to control. Most 
specimens showed well-defined capsules, except for 
MTA Fillapex, where most specimens retained a thick 
fibrous capsule (Figure 2, C1–4)
At 60 days, complete subsidence of 
inflammation occurred and almost all specimens showed 
negligible inflammatory cell infiltration. Nevertheless, a 
significant difference was absent between the groups. 
A thin mature fibrous capsule was observed around the 
implanted tubes of all specimens (Figure 2, D1–4).
Friedman test revealed a statistically significant 
decrease of the inflammation intensity and capsule 
thickness over time, within the same group of all tested 
sealers and controls.
Figure 3: Box plot showing median inflammatory scores in different 
groups
Figure  4: Bar chart illustrating frequency of different scores of 
inflammation intensity
Figure 5: Bar chart illustrating frequency of different capsule thickness 
scores
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Our study was conducted to evaluate the 
in-vivo biocompatibility of the recent BioRoot in parallel 
to MTA Fillapex and compared to AH Plus sealers.
The severity of the inflammatory response of 
the tested materials and the fibrous capsule thickness 
was investigated along four observation time intervals. 
Rat subcutaneous implantation was used, as it is the 
most common, reliable, and standardized method 
for testing the biocompatibility of materials [35]. This 
conformed to recommendations of the ISO of using 
different time intervals to evaluate both short and long-
term inflammatory response [7], [9], [25], [30].
Most sealers are toxic when freshly mixed, so 
we tested the freshly mixed state to simulate clinical 
conditions [33], [36]. The implanted polyethylene tubes 
were removed from tissue specimens after formalin 
fixation, to retain the tube space for easier histologic 
interpretation and also to facilitate sectioning of the 
paraffin blocks [31].
Regarding histological analysis results, 
inflammatory reactions were noticed in both 
experimental and control (empty tubes) groups at the 
1st week observation time. However, the experimental 
groups initially presented a severe inflammatory 
reaction relative to the moderate reaction of the control 
group. This was in agreement with Zmener et al. [24].
The initial inflammatory reaction adjacent to 
controls could be attributed to the incisions’ surgical 
trauma and the physical presence of the tubes. This is 
in contradiction with Silva et al. [37], who stated that 
empty polyethylene tubes caused no inflammatory 
reaction.
Regarding BioRoot RCS, a severe inflammatory 
response with marked angiogenesis was observed at 
7 days, similar to other tested groups; however, the 
inflammation declined over time.
Calcium silicate-based materials are known 
to release calcium ions upon interaction with tissue 
fluids. Thus, the initially severe inflammatory response 
(7 days) could be attributed to the ascending alkaline 
pH upon setting. Furthermore, the heat generated 
during setting reaction promotes inflammatory cell 
recruitment releasing cytokines [38], [39], [40]. In-vitro 
study on BioRoot by Camps et al. [18] showed that 
calcium hydroxide released during setting caused 
chronic inflammatory reactions in viable cells.
There is a substantial correlation between 
the development of the fibrous capsule and material 
biocompatibility, as it is considered the immune 
response rendering foreign bodies well tolerated by the 
tissues [20], [25], [36].
In the present study, the formation of granulation 
tissue followed by early deposition of collagen fibers 
occurred at the 1st week, in all experimental and control 
(empty tube) groups, indicating favorable interaction 
with the adjacent living tissues.
Concerning the long-term tissue response, 
a significant reduction in the inflammation intensity, 
subsequently, more organization of the collagenous 
capsule around the tubes occurred over time. A thin 
well-defined fibrous capsule was observed in all tested 
sealers similar to controls, particularly at the end of 60 
days, denoting tissue tolerance and biocompatibility of 
BioRoot RCS, MTA Fillapex, and AH Plus. This was 
corroborated by Bueno et al. [30] and Shahi et al. [41] 
who reported subsidence of inflammation over time 
with thinning of the fibrous capsule.
MTA Fillapex showed a significantly severe 
initial inflammatory reaction, this was corroborated by 
Bueno et al. [30] and Silveira et al. [42] who found it a 
normal initial finding when using MTA containing cement. 
This could be attributed to its salicylate resin matrix and to 
its high alkalinity. Moreover, its high flow and setting time 
may lead to the prolonged dissolution of toxic leachates 
into tissues [43]. Furthermore, a lot of MTA Fillapex 
specimens demonstrated a thick capsule even at 30 days’ 
period, which could be related to its high solubility [20].
Nevertheless, the variance in the inflammatory 
reaction may be attributed to different radiopacifiers, 
zirconium oxide as a radiopacifier in BioRoot is 
deliberated to be more biocompatible than bismuth oxide 
of MTA Fillapex [25]. In a study by Slompo et al. [44], 
zirconia oxide radiopacifier preserved the viability of 
fibroblasts.
Since the in-vivo tissue reaction to BioRoot 
was not studied yet, so we could not relate our results to 
previous studies. However, in a study by Mori et al. [33] 
who tested tissue reaction of biodentine, a root repair 
material having a similar composition to BioRoot, they 
found an early intense reaction which decreased by 14 
and 30 days. Furthermore, our results were consistent 
with Talabani et al. [25] and Simsek et al. [45], who 
assessed the rat subcutaneous reaction of biodentine 
and concluded it is biocompatible. Furthermore, another 
study by Chakar et al. [46] found minimal cytotoxicity with 
BioMM sealer, a sealer similar in constituents to BioRoot.
The biocompatibility of calcium silicate cement 
is mainly related to the amount of calcium release. 
Thus, the enhanced biocompatibility of BioRoot may be 
related to the Ca2+ release and high solubility rendering 
it more alkaline than MTA Fillapex [13], [25], [43].
Moreover, tri-calcium silicate which is the main 
constituent of BioRoot was shown to increase cell 
proliferation and promote osteogenic differentiation in 
a previous study [47].
Conclusion
BioRoot RCS presented a rapid recovery 
of inflammation similar to controls. Thus, within 
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the limitations of this study, it can be considered a 
biocompatible sealer with acceptable tissue tolerance. 
All tested sealers demonstrated a significant reduction 
of inflammatory reaction throughout the experimental 
periods and complete healing occurred with thinning 
of the fibrous capsule. Therefore, BioRoot-RCS, MTA 
Fillapex, and AH Plus are considered biocompatible.
To the best of our knowledge, up-to-date, there 
is no in-vivo study evaluating the tissue response to tri-
calcium silicate bioceramic sealer (BioRoot RCS). This 
research is deliberated in the first study comparing the 
tissue response to BioRoot RCS in the subcutaneous 
tissue of a rat model. Thus, further in-vivo studies are 
recommended to corroborate our findings.
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